Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dream Water is a non-prescription dietary supplement marketed as a sleep aid to help with occasional sleeplessness. It features a proprietary blend called SleepStat, which consists of three key ingredients: gamma-aminobutyric acid (GABA), melatonin, and 5-hydroxytryptophan (5-HTP). GABA acts as an inhibitory neurotransmitter to promote relaxation, melatonin helps induce sleep by regulating the circadian rhythm, and 5-HTP serves as a precursor to serotonin to improve sleep quality. Developed by Dream Products and Sarpes Beverages, the product is available in liquid shot and powder formats and does not require FDA approval as it is classified as a supplement rather than a pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dream Water.